VistaGen Therapeutics Inc. (VTGN)
NASDAQ · Healthcare
VistaGen Therapeutics Inc. Operating Income 2011–2025
VistaGen Therapeutics Inc. annual/quarterly operating income history and growth rate from 2011 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- VistaGen Therapeutics Inc. operating income for the quarter ending December 31, 2025 was -19.5 M, a 29.27% increase year-over-year.
- VistaGen Therapeutics Inc. operating income for the twelve months ending December 31, 2025 was -70.5 M, a 71.92% increase year-over-year.
- VistaGen Therapeutics Inc. annual operating income for 2025 was -56.0 M, a 69.51% increase from 2024.
- VistaGen Therapeutics Inc. annual operating income for 2024 was -33.0 M, a 44.29% decrease from 2023.
- VistaGen Therapeutics Inc. annual operating income for 2023 was -59.3 M, a 24.05% increase from 2022.
- VistaGen Therapeutics Inc. annual operating income for 2022 was -47.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
VistaGen Therapeutics Inc. Operating Income — FAQ
VistaGen Therapeutics Inc. (VTGN) operating income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is VistaGen Therapeutics Inc.'s operating income?
VistaGen Therapeutics Inc. (VTGN) reported operating income of -$56M for fiscal 2025.
Where can I see VTGN's operating income history?
The chart and table above show VistaGen Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.